FFCP PHASE1:Mm9::chr15:74756547..74756551,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=48|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr15:74756547..74756551,+|id=chr15:74756547..74756551,+|ontology_enrichment_celltype=CL:0000553!6.95e-13!6;CL:0000556!6.95e-13!6;CL:0002031!1.94e-11!25;CL:0000945!9.82e-10!1;CL:0000236!9.82e-10!1;CL:0000826!9.82e-10!1;CL:0000988!6.81e-09!32;CL:0002032!6.81e-09!32;CL:0000037!6.81e-09!32;CL:0000566!6.81e-09!32;CL:0000837!6.81e-09!32;CL:0000050!8.73e-09!9;CL:0000414!2.77e-07!11|ontology_enrichment_celltype_v019_2=CL:0000945,3.07e-86,1;CL:0000236,3.07e-86,1;CL:0000826,3.07e-86,1;CL:0000838,1.13e-08,12;CL:0000542,4.08e-08,13;CL:0000051,4.08e-08,13|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000029!2.52e-09!1;UBERON:0001097!2.52e-09!1;UBERON:0003968!2.52e-09!1;UBERON:0008785!2.52e-09!1;UBERON:0001467!2.52e-09!1;UBERON:0001421!2.52e-09!1;UBERON:0002193!8.78e-08!48;UBERON:0007823!1.80e-07!5|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0,0.140788722151667,0,0.171217968225505,0,0,0,0,0,0,0.315462165358238,0.548457734422955,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.18786951509699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258937883647172,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228778173206523,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr15:74756547..74756551,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=48 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr15:74756547..74756551,+ | |||
|description=CAGE_peak_at_chr15:74756547..74756551,+ | |||
|id=chr15:74756547..74756551,+ | |||
|ontology_enrichment_celltype=CL:0000553!6.95e-13!6;CL:0000556!6.95e-13!6;CL:0002031!1.94e-11!25;CL:0000945!9.82e-10!1;CL:0000236!9.82e-10!1;CL:0000826!9.82e-10!1;CL:0000988!6.81e-09!32;CL:0002032!6.81e-09!32;CL:0000037!6.81e-09!32;CL:0000566!6.81e-09!32;CL:0000837!6.81e-09!32;CL:0000050!8.73e-09!9;CL:0000414!2.77e-07!11 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,3.07e-86,1;CL:0000236,3.07e-86,1;CL:0000826,3.07e-86,1;CL:0000838,1.13e-08,12;CL:0000542,4.08e-08,13;CL:0000051,4.08e-08,13 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000029!2.52e-09!1;UBERON:0001097!2.52e-09!1;UBERON:0003968!2.52e-09!1;UBERON:0008785!2.52e-09!1;UBERON:0001467!2.52e-09!1;UBERON:0001421!2.52e-09!1;UBERON:0002193!8.78e-08!48;UBERON:0007823!1.80e-07!5 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0.140788722151667,0,0.171217968225505,0,0,0,0,0,0,0.315462165358238,0.548457734422955,0.42438965179803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.18786951509699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.258937883647172,0,0,0,0,0,0,0,0,0,0.884610551949874,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.184753190166605,0,0,0,0,0,0,0,0,0,0,0.163863314715738,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228778173206523,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr15:74756547..74756551,+ | |||
}} |
Latest revision as of 11:17, 5 August 2015
Short description: | p@chr15:74756547..74756551, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr15:74756547..74756551, + |
Coexpression cluster: | MCL_coexpression_mm9:48 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 3.07e-86 | 1 |
B cell | 3.07e-86 | 1 |
pro-B cell | 3.07e-86 | 1 |
lymphoid lineage restricted progenitor cell | 1.13e-08 | 12 |
lymphocyte | 4.08e-08 | 13 |
common lymphoid progenitor | 4.08e-08 | 13 |